All the news Showing 10 of 129 articles from: Health services, policy and advocacyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries Keith Alcorn / 08 January 2021 Public-sector hepatitis C treatment programmes have cured tens of thousands of people in lower- and lower-middle-income countries with the aid of low-cost direct-acting antivirals and diagnostics, a simplified approach to treatment and large-scale ... 2.5 million people in Africa need urgent hepatitis B treatment Keith Alcorn / 09 December 2020 Around 2.5 million people with hepatitis B in sub-Saharan Africa already have cirrhosis and need immediate antiviral treatment, a systematic review of published studies reports this month in the journal Liver International. Approximately ... Few countries will meet 2020 target for reducing viral hepatitis deaths Keith Alcorn / 24 November 2020 Around 1.1 million deaths were caused by viral hepatitis worldwide in 2019 and deaths due to hepatitis C are still rising despite the availability of direct-acting antiviral treatment, according to analyses of ... Can investment in hepatitis C treatment be cost saving? Keith Alcorn / 24 November 2020 Direct-acting antiviral treatment for hepatitis C can be cost saving for some countries within five to ten years, especially if they can negotiate lower drug prices, a study presented online at this ... Minimal monitoring of hepatitis C treatment is safe and effective Keith Alcorn / 17 November 2020 Hepatitis C treatment with no monitoring visits during treatment is safe and leads to a high cure rate, an international study reported on Monday at the online AASLD Liver Meeting. The study was ... Test and treat reduces hepatitis C by 83% in Melbourne gay men with HIV Keith Alcorn / 13 October 2020 Testing and treatment for hepatitis C in gay and bisexual men with HIV in Melbourne reduced the prevalence of the infection by 83% between 2012 and 2019, Australian researchers report ... Only one in four high-income countries on track for hepatitis C elimination by 2030 Keith Alcorn / 28 August 2020 Only one in four high-income countries is on track to eliminate hepatitis C by 2030 and nearly two-thirds will miss the targets by more than 20 years at current rates of progress, ... Is hepatitis elimination feasible by 2030? Keith Alcorn / 06 August 2020 Major gaps in hepatitis elimination efforts throughout the world threaten achievement of the World Health Organization (WHO) targets for achieving substantial reductions in new infections and deaths due to viral hepatitis by 2030, ... COVID-19 slows hepatitis elimination Keith Alcorn / 04 August 2020 Hepatitis elimination efforts are being severely affected by the COVID-19 pandemic in many settings, results of a 32-country survey by the World Hepatitis Alliance show. The survey of civil society hepatitis organisations and frontline ... Cameroon study shows hepatitis C treatment is feasible, highly effective in sub-Saharan Africa Keith Alcorn / 23 June 2020 High cure rates for hepatitis C can be achieved in Cameroon but the cost of treatment remains out of reach for all but the wealthiest, findings from a demonstration study of direct-acting antiviral ... ← Prev12345...13Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive